Nasopharyngeal carcinoma in Brunei Darussalam: Low incidence among the Chinese and an evaluation of antibodies to Epstein-Barr virus antigens as biomarkers

Singapore Medical Journal

Volumn 50, Issue 4, 2009, Pages 371-377

  Hsien, Y C ^a   Abdullah, M S ^b   Telesinghe, P U ^c   Ramasamy, Ranjan ^a  

^a UNIVERSITI BRUNEI DARUSSALAM   (Brunei Darussalam)

^b RIPAS HOSPITAL   (Brunei Darussalam)

^c Department of Pathology ^*

Author keywords

Cancer biomarkers; Cancer epidemiology; Epstein Barr virus antigens; IgA antibodies; Nasopharyngeal carcinoma

Indexed keywords

EARLY ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; VIRUS CAPSID ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; BRUNEI DARUSSALAM; CANCER INCIDENCE; CANCER STAGING; CHILD; CHINESE; ETHNIC GROUP; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALAYSIA; MALE; NASOPHARYNX CARCINOMA; SINGAPORE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODY SPECIFICITY; ANTIGENS, VIRAL; ASIAN CONTINENTAL ANCESTRY GROUP; BRUNEI; CAPSID PROTEINS; CHILD; CROSS-CULTURAL COMPARISON; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN A; INCIDENCE; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; REGISTRIES; SINGAPORE;

EID: 65949103212     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Chang ET, Adami HO. The enigmatic epidemiology of NPC. Cancer Epidemiol Biomarkers Prev 2006; 15:1765-1777
2. Kumar V, Abbas AK, Fausto N. Robbins and Cotran Pathologic Basis of Disease. 7th ed. Philadelphia: Saunders, 2004.
3. Sun LM, Epplein M, Li CI, Vaughan TL, Weiss NS. Trends in the incidence rates of nasopharyngeal carcinoma among Chinese Americans living in Los Angeles County and the San Francisco metropolitan area, 1992-2002. Am J Epidemiol 2005; 162:1174-1178 (Pubitemid 41785911)
4. Lo S, Lee N, Karimi S, et al. Nasopharynx, squamous cell carcinoma. In: eMedicine from WebMD [online]. Available at: www.emedicine.com/radio/topic551. htm. Accessed March 14, 2007.
5. Yang XR, Diehl S, Pfeiffer R, et al. Evaluation of risk factors for nasopharyngeal carcinoma in high-risk nasopharyngeal carcinoma families in Taiwan. Cancer Epidemiol Biomarkers Prev 2005; 14:900-905
6. Raab-Traub N. Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol 2002; 12:431-441 (Pubitemid 35370756)
7. Hadar T, Rahima M, Kahan E, et al. Significance of specific Epstein-Barr Virus IgA and elevated IgG antibodies to viral capsid antigens in nasopharyngeal carcinoma patients. J Med Virol 1986; 20:329-339
8. Puthavathana P, Kositanont U, Chongkolwatana C, et al. Prevalence of IgA specific antibodies to Epstein-Barr virus capsid and early antigens in nasopharyngeal carcinoma. Asian Pac J Allergy Immunol 1993; 11:39-43.
9. Cai WM, Li YW, Wu B, et al. Serologic diagnosis of nasopharyngeal carcinoma. A double-blind study of four EB virus antibodies with evaluation by sequential discrimination. Int J Radiat Oncol Biol Phys 1983; 9:1763-1768
10. Gan YY, Fones-Tan A, Chan SH, Gan LH. Epstein-Barr viral antigens used in the diagnosis of nasopharyngeal carcinoma. Biomed Sci 1996; 3:159-169 (Pubitemid 26290746)
11. Kim WW. Singapore Resident Population Report 1990-2006. In: Department of Statistics, Ministry of Trade & Industry, Singapore [online] 2006. Available at: www.singstat.gov.sg/pdtsvc/pubn/demo.html#pop. Accessed April 18, 2007.
12. Lim CC, Yahaya H. Second Report of the National Cancer Registry Cancer Incidence in Malaysia [online] 2004. In: National Cancer Registry, Ministry of Health, Malaysia. Available at: www.acrm.org.my/ncr/. Accessed March 20, 2007.
13. Petrie A, Sabin C. Medical Statistics at a Glance. Oxford: Blackwell, 2000.
14. Seow A, Koh WP, Chia KS, et al. Singapore Cancer Registry Report No.6 [online] 2004. In: Singapore Cancer Registry, Ministry of Health Singapore. Available at: www.hpb.gov.sg/data/hpb.home/files/edu/Appendix-C&D.pdf. Accessed March 20, 2007.
15. Yuan JM, Wang XL, Xiang YB, et al. Non-dietary risk factors for nasopharyngeal carcinoma in Shanghai, China. Int J Cancer 2000; 85:364-369 (Pubitemid 30030410)
16. Hirayama T. Descriptive and analytical epidemiology of nasopharyngeal cancer. IARC Sci PubL 1978; 20:167-189 (Pubitemid 9111595)
17. Puthavathana P, Sutthent R, Vitavasiri A, et al. Epstein-Barr virus serological markers for nasopharyngeal carcinoma in Thailand. Southeast Asian J Trop Med Public Health 1991; 22:326-331
18. Henle G, Henle W. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer 1976; 17:1-7.
19. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100:57-70. (Pubitemid 30046295)
20. Melief CJ. Cancer immunotherapy by dendritic cells. Immunity 2008; 29:372-383
21. Lo YM, Chan YS, Lo KW, et al. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res 1999; 59:1188-1191
22. Lin JC, Wang WY, Chen KY, et al. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Eng J Med 2004; 350:2461-2470
23. Tan EL, Selvaratnam G, Kananathan R, Sam CK. Quantification of Epstein-Barr virus DNA load, interleukin-6, interleukin-10, transforming growth factor-β1 and stem cell factor in plasma of patients with nasopharyngeal carcinoma. BMC Cancer 2006; 6:227. (Pubitemid 44541831)